Testing at Every Stage of Cancer Care
With over 450 specialized tests, including advanced genomic profiling,we help get you the answers you need to help more patients.
Featured Tests
From diagnosis to prognosis, treatment planning to post-treatment monitoring, our tests give youcomprehensive insights to deliver the best possible outcomes.
OmniSeq® INSIGHT
Comprehensive genomic and immune profiling gives a complete picture of the patient's tumor and details specific treatment options in one easy-to-interpret report
Labcorp® Plasma Focus™
A liquid biopsy test targeting 33 actionable genes for therapy selection
Labcorp® Plasma Complete™
A liquid biopsy test covering 521 genes, including guideline-driven and emerging biomarkers, for therapy selection
Labcorp NGS Panels
A critical component of the heme work up providing diagnostic, prognostic, and therapy selection information for myeloid and lymphoid malignancies
View Specimen Requirements
PD-L1 immunohistochemistry (IHC)
Indicated in patients with specific tumor types in order to predict their responses to treatment with PD-L1 checkpoint inhibitors
New Tests
Whole blood, bone marrow, cell pellets from whole blood or cell suspension
Whole blood, bone marrow, cell pellets from whole blood or cell suspension
Whole blood, bone marrow, cell pellets from whole blood or cell suspension
Solid tumor: formalin-fixed, paraffin-embedded (FFPE) tissue blocks or slides; thyroid fine needle aspirate (FNA)
Leukemia: whole blood or bone marrow